PULSION Medical Systems SE

MUN-PUS
Munich Stock Exchange NYSE
Surgical and Medical Instruments and Apparatus
Global Rank
#20317
Country Rank
#282
Market Cap
187.88 M
Price
22.79
Change (%)
0.00%
Volume
0

PULSION Medical Systems SE's latest marketcap:

187.88 M

As of 06/07/2025, PULSION Medical Systems SE's market capitalization has reached $187.88 M. According to our data, PULSION Medical Systems SE is the 20317th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 187.88 M
Revenue (ttm) 45.56 M
Net Income (ttm) 17.64 M
Shares Out 8.24 M
EPS (ttm) 2.14
Forward PE 0.00
Ex-Dividend Date 07/01/2025
Earnings Date 05/26/2025
Market Cap Chart
Data Updated: 06/07/2025

PULSION Medical Systems SE's yearly market capitalization.

PULSION Medical Systems SE has seen its market value drop from €179.74 M to €164.9 M since 2020, representing a total decrease of 8.26% and an annual compound decline rate (CAGR) of 1.92%.
Date Market Cap Change (%)
06/07/2025 €164.9 M 25.79%
12/30/2024 €131.09 M -0.62%
12/29/2023 €131.92 M -15.79%
12/30/2022 €156.65 M -2.07%
12/30/2021 €159.95 M -11.01%
12/30/2020 €179.74 M

Company Profile

About PULSION Medical Systems SE

PULSION Medical Systems SE specializes in the development, manufacturing, and distribution of advanced medical monitoring, diagnostic, and therapy control systems. These systems are designed for recording physiological parameters in hospitalized, seriously ill, and intensive care patients.

Key Technologies

  • PiCCO Platform: A critical care system for treating severely ill patients in intensive care.
  • PulsioFlex: Advanced technology for perioperative medicine applications.
  • PiCCO Catheter: A specialized catheter for cardiovascular system monitoring.
  • ProAQT Sensor: Designed for high-risk patients and interventions in medical settings.
  • CeVOX: Enables continuous monitoring of a patient's oxygen balance.
  • LiMON: Technology for assessing and monitoring liver function.
  • NICCI: A solution for hemodynamic monitoring in clinical environments.

Company Background

Founded in 1990, PULSION Medical Systems SE is headquartered in Feldkirchen, Germany.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.